NCT06127225 - Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 28, 2023

Primary Completion Date

August 9, 2024

Study Completion Date

August 28, 2024

Conditions

Non-Alcoholic Fatty Liver Disease (NAFLD)

Interventions

DRUG

Proliverenol

1 caplet of Proliverenol 500 mg twice daily 2 caplets of Proliverenol 500 mg once daily 2 caplets of Proliverenol 500 mg twice daily

DRUG

Placebo caplets of Proliverenol

2 caplets of Proliverenol Placebo daily

Trial Locations (1)

Division of Hepatology, Dr. Cipto Mangunkusumo Hospital, Jakarta Pusat